Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipopolysaccharide (LPS) and associated phospholipid bilayer (LPS/OM)

Target
LPS/OM
Molecular classification
Bacterial cell envelope component, Glycolipid, Phospholipid bilayer
01

Overview

The Gram-negative bacterial outer membrane is a specialized asymmetric lipid bilayer that serves as the primary interface between the bacterium and its environment. Its outer leaflet is predominantly composed of lipopolysaccharide (LPS), a complex glycolipid consisting of a conserved Lipid A anchor, a core oligosaccharide, and a variable O-antigen (Raetz & Whitfield, 2002). This structure functions as a highly selective permeability barrier, effectively excluding many hydrophobic antibiotics and detergents that would otherwise damage the cell (Nikaido, 2003). LPS is also a potent pathogen-associated molecular pattern (PAMP) recognized by the host immune system via Toll-like receptor 4 (TLR4), and its systemic release can lead to life-threatening sepsis and septic shock (Opal, 2010). Therapeutic agents like polymyxins target this structure by binding to the negatively charged phosphate groups of Lipid A, displacing stabilizing divalent cations and causing membrane disruption (Velkov et al., 2013). Newer developmental drugs, such as murepavadin, target the LptD protein responsible for transporting LPS to the outer membrane, thereby compromising the integrity of the bacterial envelope (Srinivas et al., 2010).

Other names
LipopolysaccharideEndotoxinBacterial outer membraneLipid A-core-O-antigen complexGram-negative cell envelope
02

Mechanism of action

Polymyxins bind to the Lipid A portion of LPS, displacing divalent cations (Mg2+ and Ca2+) that stabilize the membrane, leading to increased permeability and cell death (Velkov et al., 2013). Other agents inhibit the Lpt pathway, specifically the LptD/E complex, preventing the transport of LPS to the outer leaflet (Srinivas et al., 2010).

03

Biological functions

Structural integritySelective permeability barrierEndotoxin activityImmune system activation
04

Disease associations

InfectionSepsisSeptic shock
05

Safety considerations

NephrotoxicityNeurotoxicityEndotoxin-mediated systemic inflammatory response
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin Activity Assay (EAA)ProcalcitoninLipopolysaccharide-binding protein (LBP)

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipopolysaccharide (LPS) and associated phospholipid bilayer (LPS/OM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipopolysaccharide (LPS) and associated phospholipid bilayer (LPS/OM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call